Biologics quality testing. Faster, safer.

PathoQuest drives innovation in quality testing to deliver new biotherapies rapidly and safely to patients.

Why PARTNER WITH PathoQuest?

At PathoQuest, we understand that you need to develop your innovative biologics safely and timely in a complex testing environment. PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing for global biopharmaceutical and emerging biologics companies.

With a proven track record in the provision of regulated contract research services, PathoQuest offers a team of 50 genomic experts based in France and the U.S. Our expert CRO team are readily available to support with rapid and robust quality controlled (QC) testing at GMP and non-GMP level.

Let’s work together to transform the future of biologic therapies and treatments to transform patient lives.

Modalities

mAbs and Recombinants

Bacterial and mammalian produced proteins, hormones and peptides

READ MORE

Viral Vectors

Viral gene delivery, oncolytic and immunotherapy including manufacturing plasmids

READ MORE

Cell Therapies

Including gene modified, or unmodified stem cell therapies, allogeneic or autologous

READ MORE

Vaccines

Inactivated, live-attenuated, recombinant, RNA and viral vector products

READ MORE

RNA

Immunotherapies, antiviral, vaccines, RNAi and CRISPR based gene editing

READ MORE

Cultivated Meat

Engineered cells and tissues cultured in more ethical in vitro environments

READ MORE

3Rs

Next generation sequencing is the ethical alternative to in vivo testing for the quality control testing of biologics.

PathoQuest, in partnership with Charles River Laboratories, is the first CRO to conclusively demonstrate the superiority of NGS over conventional in vivo biosafety testing and characterization.

3Rs

Next generation sequencing is the ethical alternative to in vivo testing for the quality control testing of biologics.

PathoQuest, in partnership with Charles River Laboratories, are the first CRO to conclusively demonstrate the superiority of NGS over conventional in vivo biosafety testing and characterization.

SERVICES

Adventitious Virus Testing

Detection of viral contamination within the manufacturing process and beyond.

Identity Confirmation

Genetic characterization of viral and plasmid products for release.

nCats Integration Site Analysis

Characterisation of genetic modifications for clone selection, genetic stability and lot release

Cell Line Characterization

Biosafety screening and stability testing of manufacturing cells.

READ MORE

READ MORE

READ MORE

HLA Genotyping

Characterizing and screening for novel and emerging cell therapies.

In Vivo Replacement

NGS as an ethical alternative to animals in biosafety testing and characterization.

Raw Material Testing

Screening of high-risk inputs such as animal products and media.

READ MORE

READ MORE

READ MORE

SERVICES

Adventitious Virus Testing

Detection of viral contamination within the manufacturing process and beyond.

READ MORE

Identity Confirmation

Genetic characterization of viral and plasmid products for release.

READ MORE

Cell Line Characterization

Biosafety screening and stability testing of manufacturing cells.

READ MORE

HLA Genotyping

Characterizing and screening for novel and emerging cell therapies.

READ MORE

In Vivo Replacement

NGS as an ethical alternative to animals in biosafety testing and characterization.

READ MORE

Raw Material Testing

Screening of high-risk inputs such as animal products and media.

READ MORE

STRATEGIC PARTNERSHIPS

News and Events

LOOK FOR US AT THESE UPCOMING MEETINGS

  • BioProcess International – September 18th-21st, Boston, MA
  • 7th Annual Viral Safety & Viral Clearance Summit – October 3rd-4th, San Francisco, CA
  • 8th Bioproduction Congress – October 5th-6th, Lyon, France
  • Cell & Gene Meeting on the Mesa – October 10th-12th, Carlsbad, CA
  • Festival of Biologics – October 10th-12th, Basel, Switzerland
  • European Society of Gene & Cell Therapy (ESGCT) – October 24th-27th, Brussels, Belgium

Contact us

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

E: contact@pathoquest.com

Sign up for our latest news

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

E: contact@pathoquest.com

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

Sign up for our latest news